Genelabs Technologies, Inc.
(NASDAQ:GNLB)|
1.27 -0.01 (-0.78%) Dec 01 - Close |
|
|
|
After-Hours 1.28 +0.01 (0.79%) Mon, 1 Dec 2008 6:50 PM
- Compare GNLB with:
- View: Line | Candlestick
Company Profile
Genelabs Technologies, Inc.
505 Penobscot Drive
Redwood City, CA 94063
United States - Map
Phone: (650) 369-9500
Fax: (650) 368-0709
Website: www.genelabs.com
State of incorporation: California
CEO: Frederick W. Driscoll
Employees: 76
Sector: Healthcare
Industry Group: Drugs
Industry: Diagnostic Substances
Mfr/mkt biopharmaceutical products
A biopharmaceutical company is engaged in the discovery and development of infectious disease therapies to improve human health.
Recent news for GNLB
-
Navigating the Micro-Cap Biotech Minefield
Seeking Alpha - Nov 23 at 10:26 ET
-
GENELABS TECHNOLOGIES INC /CA Financials
EDGAR Online Financials - Nov 20 at 9:04 ET
-
New Star Analyst Rankings for Genelabs Technologies, Inc.
StarMine - Nov 16 at 9:33 ET
-
New Star Analyst Rankings for Genelabs Technologies, Inc.
StarMine - Nov 14 at 9:23 ET
-
GENELABS TECHNOLOGIES INC /CA Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online - Nov 13 at 4:06 ET
-
Genelabs Reports Results for the Third Quarter and First Nine Months of 2008
Business Wire - Nov 13 at 2:37 ET
-
GENELABS TECHNOLOGIES INC /CA Files SEC form 10-Q, Quarterly Report
EDGAR Online - Nov 13 at 2:12 ET
-
GlaxoSmithKline Commences Tender Offer to Acquire Genelabs Technologies, Inc.
PR Newswire - Nov 12 at 9:44 ET
-
GENELABS TECHNOLOGIES INC /CA Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online - Nov 03 at 4:04 ET
-
GlaxoSmithKline to Acquire Genelabs Technologies For $57M
Seeking Alpha - Oct 31 at 5:22 ET